{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:11:32Z","timestamp":1790734292429,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ophtha.2012.11.013","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T19:15:49Z","timestamp":1360955749000},"page":"1173-1178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Evaluation of Moxifloxacin 0.5% in Treatment of Nonperforated Bacterial Corneal Ulcers"],"prefix":"10.1016","volume":"120","clinical-trial-number":[{"clinical-trial-number":"isrctn10323655","registry":"10.18810\/isrctn"}],"author":[{"given":"Namrata","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manik","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakashchand","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeewan S.","family":"Titiyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish D.","family":"Upadhyaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasik B.","family":"Vajpayee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2012.11.013_bib1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(95)30771-3","article-title":"The importance of initial management in the treatment of severe infectious corneal ulcers","volume":"102","author":"McLeod","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.013_bib2","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ophtha.2012.11.013_bib3","first-page":"913","article-title":"Mapping the global distribution of trachoma","volume":"83","author":"Polack","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ophtha.2012.11.013_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archopht.1982.01030030079005","article-title":"Ulcerative keratitis: survey of 30 years' laboratory experience","volume":"100","author":"Asbell","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9394(14)75075-5","article-title":"Spectrum of microbial keratitis in South Florida","volume":"90","author":"Liesegang","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0039-6257(79)90127-9","article-title":"Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms","volume":"24","author":"Baum","year":"1979","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bjo.85.7.842","article-title":"Bacterial keratitis: a prospective clinical and microbiological study","volume":"85","author":"Schaefer","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/bjo.2008.151167","article-title":"Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study","volume":"93","author":"Ibrahim","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1442-9071.2006.01143.x","article-title":"Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin","volume":"34","author":"Ly","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib10","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0161-6420(96)30416-8","article-title":"Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers","volume":"103","author":"Hyndiuk","year":"1966","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.013_bib11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1993.01090090062020","article-title":"Ciprofloxacin Ointment\/Bacterial Keratitis Study Group. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis","volume":"111","author":"Wilhelmus","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9394(14)74449-6","article-title":"Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis","volume":"115","author":"Parks","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archopht.1995.01100100045026","article-title":"Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis","volume":"113","author":"O'Brien","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00003226-200103000-00013","article-title":"Bacteriologic and clinical efficacy of ofloxacin 3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis","volume":"20","author":"Prajna","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2012.11.013_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0039-6257(79)90128-0","article-title":"Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears","volume":"24","author":"Jones","year":"1979","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bjo.82.2.137","article-title":"Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers","volume":"82","author":"Bennett","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib17","series-title":"Smolin and Thoft's The Cornea: Scientific Foundations and Clinical Practice","first-page":"235","article-title":"Bacterial keratitis","author":"O'Brien","year":"2005"},{"key":"10.1016\/j.ophtha.2012.11.013_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12325-008-0107-x","article-title":"Review of third- and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy","volume":"25","author":"Scoper","year":"2008","journal-title":"Adv Ther"},{"issue":"suppl","key":"10.1016\/j.ophtha.2012.11.013_bib19","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones: mechanism of action, classification, and development of resistance","volume":"49","author":"Blondeau","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/dkg059","article-title":"Dual activity of fluoroquinolones against Streptococcus pneumoniae [letter]","volume":"51","author":"Fisher","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ophtha.2012.11.013_bib21","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.1073\/pnas.92.25.11801","article-title":"Topoisomerase IV is a target of quinolones in Escherichia coli","volume":"92","author":"Khodursky","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2012.11.013_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/AAC.41.1.175","article-title":"Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV","volume":"41","author":"Breines","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ophtha.2012.11.013_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jac\/45.5.583","article-title":"Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones","volume":"45","author":"Pestova","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ophtha.2012.11.013_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-9394(14)76770-4","article-title":"An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations","volume":"111","author":"Bowe","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/ajhp\/55.5.463","article-title":"Storage of extemporaneously prepared ophthalmic antimicrobial solutions","volume":"55","author":"Charlton","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ophtha.2012.11.013_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1440-1606.1999.00239.x","article-title":"In vitro potency and stability of fortified ophthalmic antibiotics","volume":"27","author":"Arici","year":"1999","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1755-3768.2008.01306.x","article-title":"Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus","volume":"87","author":"Karampatakis","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib28","first-page":"881","article-title":"Comparative bioavailability and efficacy of fortified topical tobramycin","volume":"28","author":"Gilbert","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2012.11.013_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/bjo.84.4.378","article-title":"Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers","volume":"84","author":"Gangopadhyay","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00003226-200003000-00014","article-title":"Effect of fortified antibiotic solutions on corneal epithelial wound healing","volume":"19","author":"Lin","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2012.11.013_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/ICO.0b013e3181ca2ba3","article-title":"Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers","volume":"29","author":"Shah","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2012.11.013_bib32","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","article-title":"Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial","volume":"114","author":"Constantinou","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.013_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3129\/i10-054","article-title":"Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial","volume":"46","author":"Blair","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archophthalmol.2011.315","article-title":"Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT)","volume":"130","author":"Srinivasan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcrs.2005.12.108","article-title":"Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery","volume":"32","author":"Moshirfar","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2012.11.013_bib36","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jcrs.2007.04.015","article-title":"Fourth-generation fluoroquinolone-resistant bacterial keratitis","volume":"33","author":"Jhanji","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2012.11.013_bib37","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.jcrs.2007.07.019","article-title":"Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis","volume":"33","author":"Moshirfar","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2012.11.013_bib38","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0161-6420(99)00717-4","article-title":"Ciprofloxacin-resistant Pseudomonas keratitis","volume":"106","author":"Garg","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.013_bib39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9394(14)71801-X","article-title":"Ciprofloxacin-resistant bacterial keratitis","volume":"114","author":"Snyder","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.013_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0161-6420(99)90008-8","article-title":"In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: emerging resistance","volume":"106","author":"Kunimoto","year":"1999","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012010925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012010925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:03:56Z","timestamp":1758981836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642012010925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0161642012010925"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.11.013","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Moxifloxacin 0.5% in Treatment of Nonperforated Bacterial Corneal Ulcers","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}